[Antituberculous drugs and pregnancy (author's transl)].
D010131:Aminosalicylic Acid / Q000009:adverse effects; D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects*; D002642:Chick Embryo; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D004977:Ethambutol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D051379:Mice; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D051381:Rats; D012293:Rifampin / Q000009:adverse effects; D013723:Teratogens
D000995:Antitubercular Agents; D013723:Teratogens; D010131:Aminosalicylic Acid; D004977:Ethambutol; D004096:Dihydrostreptomycin Sulfate; D007538:Isoniazid; D012293:Rifampin
Antituberculeux et grossesse.